Surveillance Practice for MRSA

MRSA has emerged as one of the predominant pathogens in healthcare-associated infections. Treatment options for MRSA are limited and less effective than options available for susceptible S. aureus infections and result in higher morbidity and mortality. Hospitals are debating whether to swab every patient upon admission for Methicillin-Resistant Staphylococcus aureus, or just every patient admitted to the intensive care unit, or just certain patient populations such as those undergoing dialysis or those in pediatric settings. Current estimates suggest that 49-65% of healthcare-associated S. aureus infections reported to NHSN are caused by methicillin- resistant strains.

  • Pathogenesis
  • Epidemiology
  • HHS Prevention Targets

Related Conference of Surveillance Practice for MRSA

August 28-29, 2025

8th Pathology and Infectious Disease Conference

London, UK
September 22-23, 2025

11th International Conference on Infectious and Rare Diseases

Vancouver, Canada
December 11-12, 2025

8th Annual Congress on Bacterial, Viral and Infectious Diseases

Prague, Czech Republic
December 15-16, 2025

7th Global Experts Meeting on Infectious Diseases

Barcelona, Spain
December 17-18, 2025

17th Global Conference on Nephrology and Infectious Diseases

Amsterdam, Netherlands

Surveillance Practice for MRSA Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in